August 21, 2025
Bethlehem, PA — B. Braun Medical has initiated a nationwide recall of two intravenous fluid products after identifying the presence of particulate matter in certain lots, according to a company statement and confirmation by the U.S. Food and Drug Administration (FDA). The affected products include Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL.
The recall, announced on August 21, was prompted after internal quality control inspections revealed particulate contamination that could pose serious health risks to patients. The company warned that administration of IV fluids containing particulates may lead to phlebitis, systemic inflammatory response, embolization, or even organ dysfunction if infused.
Scope of the Recall
B. Braun confirmed that the recall affects multiple distribution lots shipped across the United States. The fluids are widely used in surgical, critical care, and outpatient settings for hydration, electrolyte balance, and as a carrier for drug administration. Given the essential role of IV fluids in perioperative care, the recall is expected to create significant strain on hospital inventories.
Potential Patient Risks
The FDA emphasized the risks associated with contaminated IV solutions, noting that the particulates identified may originate from manufacturing or packaging processes. Infusion of contaminated solutions could cause bloodstream infections, blockages in capillaries, or foreign body responses, leading to severe complications.
While no adverse events have yet been reported in connection with the recalled products, both B. Braun and the FDA are urging clinicians to monitor patients closely if suspect lots were used and to report any complications through the FDA’s MedWatch program.
Impact on Surgical and Critical Care Markets
The recall is especially concerning for surgical teams and anesthesiologists, who rely on sterile IV fluids as a foundation for patient management during procedures. Anesthesiology practices, in particular, often depend on Lactated Ringer’s solution for fluid resuscitation and volume management. A sudden shortage or interruption could complicate case scheduling and perioperative planning.
Hospital supply chain managers are already facing challenges from recent medical device shortages, including pediatric ventricular assist devices and infusion pump concerns. This new recall adds to the cumulative burden, forcing institutions to reallocate resources, identify alternate suppliers, and implement conservation protocols.
"This is not a recall that hospitals can work around easily," said Dr. Michael Tran, Chief of Anesthesiology at a large Midwest health system. "IV fluids are the backbone of surgical care. If inventory is compromised, surgical throughput, ICU management, and even emergency care can all be disrupted."
Hospital and Supply Chain Response
